Document is current
Any future updates will be listed below
-
Authors
Lin, Chun-Fu
Chen, Yu-Hui
Yeh, Chang-Ching
Hsu, Sanford P. C.
Fu, Yu-Show https://orcid.org/0000-0002-4754-6006
-
Funding
Funding for this research was provided by:
Taipei Veterans General Hospital (V114C-203)
Lee Liang-Shong Neurosurgery Foundation in Taipei
National Science and Technology Council in Taiwan (113-2314-B-075-061)
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 23 June 2025
First Online: 22 July 2025
Declarations
:
: All authors declare there is no conflict of interest.
: Not applicable.
: The ethics approval for the research project titled “The outcomes and mechanism of xenografting of human umbilical mesenchymal stem cells from Wharton’ s jelly on mouse amyotrophic lateral sclerosis” was granted by the Medical and Laboratory Animal Ethics Committee of National Yang Ming Chiao Tung University, Taipei. The approval number for this project is 1100306, and the date of approval is March 06, 2021. All animals involved in the study were handled in accordance with ethical guidelines, and their care and use were approved by the Medical and Laboratory Animal Ethics Committee of National Yang Ming Chiao Tung University.The use of human umbilical cord in this study was approved by the research project titled “The outcomes and mechanism of xenografting of human umbilical mesenchymal stem cells from Wharton’ s jelly on mouse amyotrophic lateral sclerosis” and granted by the Institutional Review Board of Taipei Veterans General Hospital. The ethics approval number for this project is 2021–01-009BC, and the date of approval is January 07, 2021. All expectant mothers who choose to donate their umbilical cords have provided written informed consent for the use of umbilical cords in this study.
